About Dhanvantari Biosciences Private Limited
Data last updated:
Dhanvantari Biosciences Private Limited is a private limited company based in Visakhapatnam, Andhra Pradesh, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 22 March 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U74999AP2017PTC105482. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rudraraju Venkata Viswa Bangaru Raju and Sowmya Dantuluri.
Its last annual general meeting (AGM) was held on 30 September 2019, and its latest financial statements are for the year ended 31 March 2019. The registered office is at D No.507 J V Agraharam Panchayathi Bheemili Mandal, Visakhapatnam, Andhra Pradesh, India – 531163.
As per the financials filed for FY 2019, the company reported a revenue of ₹18.94 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net loss of ₹21.06 Lakh (net margin -111.2%) and EBITDA of -₹16.29 Lakh (EBITDA margin -86%).
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dhanvantary.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Apps
- Registered AddressD No.507 J V Agraharam Panchayathi Bheemili Mandal, Visakhapatnam, Andhra Pradesh, India – 531163
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Dhanvantari Biosciences Private Limited
FY 2019 filings availableDhanvantari Biosciences Private Limited reported revenue of ₹18.94 Lakh (up 9% YoY) for FY 2019.
Compounded Annual Growth Rate (CAGR)
Revenue rose 9% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2018-19 | FY 2016-17 to FY 2017-18in the company report |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ₹18.94 Lakh | |
| Other Income | •••• | |
| Total Revenue | •••• | |
| Cost of Materials Consumed | •••• | |
| Employee Benefit Expense | •••• | |
| Finance Costs | •••• | |
| Depreciation and Amortisation | •••• | |
| Other Expenses | •••• | |
| Total Expenses | •••• | |
| EBITDA | -₹16.29 Lakh | |
| Profit Before Tax | •••• | |
| Tax Expense | •••• | |
| Net Profit (PAT) | -₹21.06 Lakh | |
| Balance Sheet | ||
| Share Capital | •••• | |
| Reserves and Surplus | •••• | |
| Net Worth (Total Equity) | •••• | |
| Long-term Borrowings | •••• | |
| Short-term Borrowings | •••• | |
| Trade Payables | •••• | |
| Total Liabilities | •••• | |
| Fixed Assets | •••• | |
| Investments | •••• | |
| Inventories | •••• | |
| Trade Receivables | •••• | |
| Cash and Bank Balance | •••• | |
| Total Assets | •••• | |
Financial Ratios
| Metrics | FY 2018-19 | FY 2016-17 to FY 2017-18in the company report |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -86% | |
| Net Profit Margin | -111.2% | |
| Return on Equity (ROE) | •••• | |
| Return on Capital Employed (ROCE) | •••• | |
| Return on Assets (ROA) | •••• | |
| Liquidity and Debt | ||
| Current Ratio | •••• | |
| Quick Ratio | •••• | |
| Debt-to-Equity Ratio | •••• | |
| Interest Coverage Ratio | •••• | |
| Efficiency and Growth | ||
| Asset Turnover | •••• | |
| Receivable Days | •••• | |
| Payable Days | •••• | |
| Inventory Days | •••• | |
| Revenue Growth | •••• | |
| Net Profit Growth | •••• | |
Paid data: the figures shown as dots, and every line for FY 2016-17 to FY 2017-18, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dhanvantari Biosciences are in the company report.
Financial statements from FY 2017
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Board of Directors of Dhanvantari Biosciences Private Limited
Dhanvantari Biosciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sowmya Dantuluri | Additional Director | 30 Aug 2021 | 5 Years 1 Months | Current |
| Rudraraju Venkata Viswa Bangaru Raju | Director | 22 Mar 2017 | 9 Years 7 Months | Current |
Auditor Details
Dhanvantari Biosciences Private Limited is audited by V GOVINDA RAJU & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V GOVINDA RAJU & ASSOCIATES | Locked | Locked | Locked |
: available in the company report
Ownership and Shareholding
: available in the company report
Charges & Borrowings
Dhanvantari Biosciences Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance
Employment history and EPFO contributions of people linked to Dhanvantari Biosciences.
: available in the company report
Recent Activity
Dhanvantari Biosciences Private Limited has 4 board changes on record since 2017: 2 appointments and 2 cessations. The latest: Dantuluri Leelasamskruthi ceased to be Managing Director on 29 Mar 2022.
Credit Ratings, Litigation & Regulatory Alerts
: available in the company report
MSME Payment Delays
: available in the company report
Subsidiaries & Group Companies
: available in the company report
GST Compliance
Dhanvantari Biosciences has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
: available in the company report
MCA Filings & Documents
: available in the company report
Frequently Asked Questions
Dhanvantari Biosciences is an active private limited company based in Visakhapatnam, Andhra Pradesh, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 22 March 2017 (9+ years old) and is registered under CIN U74999AP2017PTC105482.
Dhanvantari Biosciences has 2 current directors:
- Sowmya Dantuluri - Additional Director
- Rudraraju Venkata Viswa Bangaru Raju - Director
The latest financial statements of Dhanvantari Biosciences on record with the MCA are for the year ended 31 March 2019. Its last annual general meeting was held on 30 September 2019. Year-wise statements from FY 2017 are in the company report.
No. Dhanvantari Biosciences has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Dhanvantari Biosciences is U74999AP2017PTC105482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dhanvantari Biosciences was incorporated on 22 March 2017, making it 9+ years old. It is registered with the Registrar of Companies, Vijayawada.
Dantuluri Leelasamskruthi ceased to be Managing Director on 29 Mar 2022. Sowmya Dantuluri was appointed as Additional Director on 30 Aug 2021. Muniyan Munisamy ceased to be Director on 21 Mar 2020. Dhanvantari Biosciences has 4 board changes on record in total.
Dhanvantari Biosciences can be reached through the website dhanvantary.com. Its registered office is in Visakhapatnam, Andhra Pradesh, India.
The registered office of Dhanvantari Biosciences is at D No.507 J V Agraharam Panchayathi Bheemili Mandal, Visakhapatnam, Andhra Pradesh, India – 531163.
Dhanvantari Biosciences operates in the healthcare industry, in the ayurvedic products and services segment.